|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
GB9621367D0
(en)
*
|
1996-10-14 |
1996-12-04 |
Isis Innovation |
Chiral peptide nucleic acids
|
|
US6326479B1
(en)
*
|
1998-01-27 |
2001-12-04 |
Boston Probes, Inc. |
Synthetic polymers and methods, kits or compositions for modulating the solubility of same
|
|
US8206749B1
(en)
|
1999-02-26 |
2012-06-26 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
|
WO2002042316A2
(en)
*
|
2000-11-24 |
2002-05-30 |
Pantheco A/S |
Pna analogues
|
|
WO2002053574A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Pantheco A/S |
Modified pna molecules
|
|
US6716961B2
(en)
*
|
2001-10-30 |
2004-04-06 |
Isis Innovation Limited |
Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone
|
|
DE60324426D1
(de)
*
|
2002-02-04 |
2008-12-11 |
Isis Innovation |
Pyrrolidinyl peptid nukleinsäure
|
|
US8604183B2
(en)
|
2002-11-05 |
2013-12-10 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
|
|
DE602004030114D1
(de)
*
|
2003-05-20 |
2010-12-30 |
Investigen Inc |
System zum nachweis von polynukleotiden
|
|
EP1644475A4
(en)
|
2003-06-20 |
2009-06-03 |
Isis Pharmaceuticals Inc |
DOUBLE-STRAND COMPOSITIONS WITH A 3'-ENDO-MODIFIED STRING FOR USE IN GENE MODULATION
|
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
|
WO2007100711A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
US20080096193A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
US8324359B1
(en)
|
2006-12-04 |
2012-12-04 |
Luminex Corporation |
Oxocarbonamide peptide nucleic acids and methods of using same
|
|
WO2008103702A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Investigen, Inc. |
Methods and compositions for rapid light-activated isolation and detection of analytes
|
|
US7964355B2
(en)
*
|
2009-02-17 |
2011-06-21 |
Investigen, Inc. |
Assays based on detection of photobleaching reaction products from dye catalytic complex
|
|
US8785121B2
(en)
|
2010-07-08 |
2014-07-22 |
Bonac Corporation |
Single-stranded nucleic acid molecule for controlling gene expression
|
|
US8691782B2
(en)
|
2010-08-03 |
2014-04-08 |
Bonac Corporation |
Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
|
|
ES2527660T3
(es)
*
|
2010-08-03 |
2015-01-28 |
Bonac Corporation |
Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
|
|
CN109810977A
(zh)
|
2012-05-26 |
2019-05-28 |
株式会社博纳克 |
具有递送功能的基因表达调控用单链核酸分子
|
|
CN105899663B
(zh)
|
2013-12-26 |
2019-07-26 |
学校法人东京医科大学 |
用于基因表达控制的人工模拟miRNA及其用途
|
|
SG10201913570XA
(en)
|
2013-12-27 |
2020-03-30 |
Bonac Corp |
Artificial match-type mirna for controlling gene expression and use therefor
|
|
SG11201705223XA
(en)
|
2014-12-27 |
2017-07-28 |
Bonac Corp |
NATURALLY OCCURING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME
|
|
JP6602847B2
(ja)
|
2015-03-27 |
2019-11-06 |
株式会社ボナック |
デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子
|